Replication data for: Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids
Principal Investigator(s): View help for Principal Investigator(s) Abby Alpert; David Powell; Rosalie Liccardo Pacula
Version: View help for Version V1
Name | File Type | Size | Last Modified |
---|---|---|---|
data | 10/13/2019 06:04:AM | ||
LICENSE.txt | text/plain | 14.6 KB | 10/13/2019 02:04:AM |
Project Citation:
Alpert, Abby, Powell, David, and Pacula, Rosalie Liccardo. Replication data for: Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids. Nashville, TN: American Economic Association [publisher], 2018. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2019-10-13. https://doi.org/10.3886/E114713V1
Project Description
Summary:
View help for Summary
Overdose deaths from prescription opioid pain relievers nearly quadrupled between 1999 and 2010. We study the consequences of one of the largest supply disruptions to date to abusable opioids—the introduction of an abuse-deterrent version of OxyContin in 2010. Supply-side interventions which limit access to opioids may have the unintended consequence of increasing use of substitute drugs, including heroin. Exploiting cross-state variation in OxyContin exposure, we find that states with the highest initial rates of OxyContin misuse experienced the largest increases in heroin deaths. Our results imply that the recent heroin epidemic is largely due to the reformulation of OxyContin.
Scope of Project
JEL Classification:
View help for JEL Classification
I12 Health Behavior
I18 Health: Government Policy; Regulation; Public Health
I12 Health Behavior
I18 Health: Government Policy; Regulation; Public Health
Related Publications
Published Versions
Report a Problem
Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.
This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.